Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Giant linear plasmids in Mycobacterium avium harbour a tRNA array unit.

DNA research : an international journal for rapid publication of reports on genes and genomes·2026
Same author

Variability of macrolide-resistant profile in <i>Mycobacterium avium</i> complex pulmonary disease.

Antimicrobial agents and chemotherapy·2024
Same author

Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasis.

Respiratory investigation·2024
Same author

The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease.

BMC pulmonary medicine·2024
Same author

Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study.

Respiratory investigation·2024
Same author

MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study.

Journal of clinical microbiology·2023
Same journal

[EXTERNAL QUALITY ASSESSMENT OF ANTI-TUBERCULOSIS DRUG SUSCEPTIBILITY TESTING FOR DIAGNOSING EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS].

Kekkaku : [Tuberculosis]·2019
Same journal

[CLINICAL INVESTIGATION OF 6 CASES OF TUBERCULOUS SPONDYLITIS].

Kekkaku : [Tuberculosis]·2019
Same journal

[CONTROLLING TUBERCULOSIS IN FOREIGN-BORN PERSONS IN JAPAN].

Kekkaku : [Tuberculosis]·2019
Same journal

[EXPERIENCE OF USE OF NEW ANTI-TUBERCULOUS DRUG, DELAMANID IN MULTI- AND EXTENSIVELY DRUG RESISTANT TUBERCULOSIS CASES IN OUR HOSPITAL].

Kekkaku : [Tuberculosis]·2019
Same journal

[MYCOBACTERIOSIS ASSOCIATED WITH ADMINISTRATION OF BIOLOGICS].

Kekkaku : [Tuberculosis]·2019
Same journal

[PULMONARY TUBERCULOSIS AND TUBERCULOUS PLEURISY COMPLICATED WITH RIFAMPICIN-INDUCED HYPOTHYROIDISM: A CASE REPORT].

Kekkaku : [Tuberculosis]·2019
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.5K

[NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE].

Seigo Kitada

    Kekkaku : [Tuberculosis]
    |January 17, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Nontuberculous mycobacterial (NTM) lung disease, particularly Mycobacterium avium complex (MAC), is rising globally. This report details its epidemiology, diagnosis, and treatment, highlighting areas needing further research.

    More Related Videos

    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
    08:17

    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

    Published on: August 25, 2017

    11.5K
    Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
    02:34

    Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

    Published on: May 10, 2024

    1.9K

    Related Experiment Videos

    Last Updated: Jan 30, 2026

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
    07:10

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

    Published on: August 24, 2019

    10.5K
    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
    08:17

    Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

    Published on: August 25, 2017

    11.5K
    Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
    02:34

    Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

    Published on: May 10, 2024

    1.9K

    Area of Science:

    • Pulmonology
    • Infectious Diseases
    • Microbiology

    Background:

    • Nontuberculous mycobacterial (NTM) pulmonary disease is increasingly prevalent in Japan and worldwide.
    • Mycobacterium avium complex (MAC) is the most frequent cause of NTM lung disease.
    • Recognition of the importance of diagnosing and managing NTM lung disease has grown.

    Purpose of the Study:

    • To provide an updated overview of NTM lung disease.
    • To focus on Mycobacterium avium complex (MAC) lung disease.
    • To cover epidemiology, clinical features, diagnosis, and treatment strategies.

    Main Methods:

    • Review of current literature and clinical data on NTM lung disease.
    • Analysis of epidemiological trends in Japan and globally.
    • Synthesis of diagnostic approaches, including serodiagnosis.
    • Examination of treatment strategies for MAC lung disease.

    Main Results:

    • The report synthesizes the latest epidemiological data for NTM lung disease.
    • It details the clinical characteristics, disease types, and progression patterns.
    • Current diagnostic methods and therapeutic interventions for MAC lung disease are presented.

    Conclusions:

    • NTM lung disease, especially MAC, presents a growing global health challenge.
    • Comprehensive understanding of its epidemiology, clinical presentation, and progression is crucial.
    • Further research is essential to address existing challenges in NTM lung disease management.